Sorafenib improves rituximab and ofatumumab efficacy by decreasing the expression of complement regulatory proteins
Authors: Dwojak M, Bobrowicz M, Bil J, Bojarczuk K, Pyrzynska B, Siernicka M, Malenda A, Lech-Maranda E, Tomczak W, Giannopoulos K, Golab J, Winiarska M
Published in: Blood Cancer Journal
Publication type: article
Subject areas: Medicine
SJR best quartile: Q1